Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|93|3|177-182

ISSN： 0030-2414

Source： Oncology, Vol.93, Iss.3, 2017-05, pp. : 177-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Study of High-Dose Epirubicin in Platinum-Pretreated Patients with Ovarian Carcinoma

By  

Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. : 10-16

Karger

Access to resources Recommend Favorite

A Study on the Activation Peptide Released from Procarboxypeptidase B (CAPAP) and Anionic Trypsinogen in Patients with Acute Abdominal Disorders of Non-Pancreatic Origin

By  

Pancreatology, Vol. 3, Iss. 2, 2003-05 ,pp. : 149-155

Karger

Access to resources Recommend Favorite

Risk of all‐type cancer, hepatocellular carcinoma, non‐Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 10, 2015-10 ,pp. : 828-834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

By  

Oncology Research and Treatment, Vol. 35, Iss. 10, 2012-09 ,pp. : 576-580

Karger

Access to resources Recommend Favorite

Feasibility and Toxicity of Weekly Paclitaxel-Carboplatin in 131 Patients with Pretreated and Non-Pretreated Solid Tumors

By  

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 152-157

Karger

Access to resources Recommend Favorite